Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

Cardiovascular

Cardiovascular

The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment. read more

Items 1-10 of 32

Page
per page
  1. Endostatin (84-114)-NH2 (JKC367)
    A1109 Endostatin (84-114)-NH2 (JKC367)
    Summary: Angiogenesis inhibitor
      ≥353.2 mg/mL
  2. Endothelin-1 (1-15), amide, human
    A1111 Endothelin-1 (1-15), amide, human
    Summary: Vasoconstrictor agent
      Soluble in water or 1% acetic acid
  3. Nitric Oxide Synthase (599-613) Blocking Peptide, Bovine Endothelial Cell
    A1112 Nitric Oxide Synthase (599-613) Blocking Peptide, Bovine Endothelial Cell
    Summary: Blocker of NO production
      ≥196.3 mg/mL
  4. heparin cofactor II precursor (SERPIND1) fragment [Homo sapiens]
    A1143 heparin cofactor II precursor (SERPIND1) fragment [Homo sapiens]
    Summary: Thrombin inhibitor
      ≥65.1 mg/mL
  5. heparin cofactor II precursor fragment [Homo sapiens]
    A1144 heparin cofactor II precursor fragment [Homo sapiens]
    Summary: Thrombin inhibitor
      ≥140.7 mg/mL
  6. Adrenomedullin (1-12), human
    A1001 Adrenomedullin (1-12), human
    Summary: Vasodilator
      insoluble in EtOH; ≥151.3 mg/mL
  7. Angiotensin 1/2 (1-9)
    A1007 Angiotensin 1/2 (1-9)
    Summary: Vasoconstrictor
      ≥118.3 mg/mL
  8. ANP (1-11), rat
    A1009 ANP (1-11), rat
    Summary: Vasodilator
      ≥122.5 mg/mL
  9. Ac-Endothelin-1 (16-21), human
    A1016 Ac-Endothelin-1 (16-21), human
    Summary: ETA/ETB agonist,vasoconstrictor
      insoluble in EtOH; insoluble in H2O; ≥83.8 mg/mL
  10. Platelet Membrane Glycoprotein IIB Peptide (296-306)
    A1018 Platelet Membrane Glycoprotein IIB Peptide (296-306)
    Summary: Inhibits platelet aggregation
      ≥119.8 mg/mL

Items 1-10 of 32

Page
per page